Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 72Gastrointestinal 28Other hematologic neoplasm 27Genitourinary 25Lymphoid 22Thoracic 14Other 9Plasma cell 8Head & Neck 5Gynecologic 5CNS 5Endocrine 2Dermatologic 2

Conditions

Melanoma 3Skin Neoplasms 2Motor Activity 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 2Nivolumab 2Ipilimumab 2Exercise 2cemiplimab 1avelumab 1Psychology, Positive 1Methods 1Immunotherapy 1Immune Checkpoint Inhibitors 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Motor Activity × Exercise × Dermatologic × Clear all
NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT06860880 2025-06-27

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

UNC Lineberger Comprehensive Cancer Center

Phase NA Recruiting
40 enrolled
DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Motor Activity, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡